Expert oncologist Michael Birrer, MD, PhD, reviews the case of a 70-year-old woman with advanced endometrial carcinoma and considers her ideal treatment pathway.
EP. 1: Overview: A 70-Year-Old Woman With Advanced Endometrial Cancer
Expert perspectives on the work-up and management of a 70-year-old woman who is diagnosed with advanced endometrial carcinoma.
EP. 2: Endometrial Cancer: Risk Factors and Diagnostic Work-up
Focused discussion on risk factors that may drive endometrial cancer followed by advice on optimal diagnostic work-up.
EP. 3: Treatment Armamentarium for Advanced Endometrial Cancer
A broad look at the systemic and targeted therapies available for patients diagnosed with advanced endometrial carcinoma.
EP. 4: KEYNOTE-158: Pembrolizumab Use in Advanced Endometrial Cancer
Michael Birrer, MD, PhD, considers the role of pembrolizumab in advanced endometrial cancer given results from KEYNOTE-158.
EP. 5: Advanced Endometrial Cancer: Optimal Sequencing of Therapy
Insight on the optimal sequencing of therapy in patients with advanced endometrial cancer based on MMR and MSI status.
EP. 6: Combination Pembrolizumab-Lenvatinib in Advanced Endometrial Cancer
Expert perspectives on Study 309/KEYNOTE-775, which combined pembrolizumab with lenvatinib in patients with advanced endometrial carcinoma.
EP. 7: Advanced Endometrial Cancer: Future Directions in Care
Closing out his discussion on advanced endometrial carcinoma, Michael Birrer, MD, PhD, shares his hope for future treatment advances.
2 Clarke Drive Cranbury, NJ 08512